(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(-0.10%) $79.98
(1.41%) $2.66
(0.93%) $2 439.80
(4.08%) $32.54
(0.94%) $1 100.20
(-0.03%) $0.920
(-0.06%) $10.67
(0.02%) $0.787
(0.09%) $91.05
@ $8.42
Išleistas: 9 vas. 2024 @ 22:16
Grąža: -30.29%
Ankstesnis signalas: vas. 7 - 16:30
Ankstesnis signalas:
Grąža: 6.85 %
Live Chart Being Loaded With Signals
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 215 796 |
Vidutinė apimtis | 200 644 |
Rinkos kapitalizacija | 179.31M |
EPS | $0 ( 2024-03-21 ) |
Kita pelno data | ( $-0.260 ) 2024-06-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.74 |
ATR14 | $0.0210 (0.36%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-01 | Schechter Joshua | Buy | 9 554 | Common Stock |
2024-02-01 | Schechter Joshua | Sell | 9 554 | Restricted Stock Units |
2024-02-01 | Calloway Nathaniel | Buy | 3 981 | Common Stock |
2024-02-01 | Calloway Nathaniel | Sell | 3 981 | Restricted Stock Unit |
2024-02-01 | Obus Nelson | Buy | 9 554 | Common Stock |
INSIDER POWER |
---|
67.30 |
Last 64 transactions |
Buy: 1 321 123 | Sell: 150 606 |
Tūris Koreliacija
Lifecore Biomedical, Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Lifecore Biomedical, Inc. Koreliacija - Valiuta/Žaliavos
Lifecore Biomedical, Inc. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $103.27M |
Bruto pelnas: | $27.29M (26.43 %) |
EPS: | $-3.41 |
FY | 2023 |
Pajamos: | $103.27M |
Bruto pelnas: | $27.29M (26.43 %) |
EPS: | $-3.41 |
FY | 2023 |
Pajamos: | $103.27M |
Bruto pelnas: | $27.29M (26.43 %) |
EPS: | $-3.41 |
FY | 2022 |
Pajamos: | $185.79M |
Bruto pelnas: | $50.37M (27.11 %) |
EPS: | $-3.29 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.